Results 131 to 140 of about 9,672 (236)

Resultados del tratamiento de la hepatitis C con antivirales de acción directa [PDF]

, 2016
La Hepatitis C (VHC) es la causa más frecuente de cirrosis hepática en el mundo occidental. En el último año, la aparición de nuevos antivirales de acción directa (AAD) ha mejorado la tasa de respuesta viral sostenida (RVS) y la seguridad del tratamiento.
Romero Moreno, Sarai
core  

Development And Validation Of Stability Indicating Rp-Hplc Method For Simultaneous Estimation Of Sofosbuvir And Ledipasvir In Tablet Dosage Form

, 2018
M.Prasanthi Evangelin
openalex   +2 more sources

Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case Report [PDF]

, 2018
Giovanni Covini, Elena Bredi, Salvatore Badalamenti, Massimo Roncalli, Alessio Aghemo, Massimo Colombo   +5 more
openalex   +1 more source

Relapse of HCV Genotype 1b Infection After Sofosbuvir/Ledipasvir Treatment Presenting as De Novo Cryoglobulinemic Vasculitis

, 2017
Mohammad Qasim Khan, Alan D. Moreno, Nora Joseph, George Kim, Claus J. Fimmel   +4 more
openalex   +1 more source

Sofosbuvir/Ledipasvir - new pharmaceutical approach against hepatitis C

, 2015
Dayana Gergova, Patrisiya Georgieva, Stanila Stoeva, Krasen Tonev, Totka Cherneva, Svetlana Georgieva, Ivo Kumanov   +6 more
openalex   +2 more sources

Effect of Sofosbuvir/Ledipasvir and Glecaprevir/Pibrentasvir on Serum Creatinine

, 2021
Waseem Amjad, Talan Zhang, Anurag Maheshwari, Paul J. Thuluvath   +3 more
openalex   +2 more sources

Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/Sofosbuvir: Table 1. [PDF]

, 2016
Curtis Cooper, Susanna Naggie, Michael S. Saag, Jenny C. Yang, Luisa M. Stamm, Hadas Dvory‐Sobol, Lingling Han, Phillip S. Pang, John G. McHutchison, Douglas T. Dieterich, Mark Sulkowski   +10 more
openalex   +1 more source

Anti-HCV NS2-3 potential of selected plant bioactive compounds revealed by docking, simulation and DFT. [PDF]

Sci Rep
Mboto CI, Mbim EN, Edet UO, Lugos M, Abdalla M, Ndifon WO, Ebenso EE, Udo SI, Egharevba HO, George UE, El-Sayed MH, Abdalla SF.   +11 more
europepmc   +1 more source

Ledipasvir and Sofosbuvir in the Treatment of Early Hepatitis C Virus Infection in HIV-Infected Men [PDF]

, 2018
Paari M Palaniswami, Ahmed El Sayed, Benjamin Asriel, Jesse R Carollo, Daniel S. Fierer, the New York Acute Hepatitis C Surveillance Network, Bisher Akil, Juan Bailey, Paul Bellman, Daniel T. Bowers, Krisczar Bungay, Susanne Burger, Aviva Cantor, Rachel Chasan, Robert Chavez, Rita Chow, Robert M. Cohen, Patrick Dalton, John Dellosso, Stephen M. Dillon, Eileen Donlon, Terry Farrow, Jose Fefer, Michael Gaisa, Rodolfo Guadron, Stuart Haber, Susan Hefron, Lawrence Higgins, Lawrence Hitzeman, Ricky Hsu, Shirish Huprikar, Victor Inada, Sneha Jacob, Livette Johnson, Barbara Johnston, Donald Kaminsky, Oscar Klein, Jeffrey Kwong, José Lares-Guia, E. H. Leach, Randy L. Levine, Irina Linetskaya, Л. С. Литвинова, Amisha Malhotra, William Mandell, Martin Markowitz, Gal Mayer, Eddie Meraz, Erik Mortensen, Joseph Olivieri, Charles Paolino, Punyadech Photangtham, George Psevdos, Asa Radix, Steven Rapaport, Roona Ray, Gabriela Rodriguez-Caprio, William Shay, Nirupama Somasundaram, Lembitu Sorra, Richie Tran, Antonio Urbina, Rona M. Vail, Francis Wallach, Wen Wang, Susan R. Weiss, Melissa Wiener   +66 more
openalex   +1 more source

Identification of Candidate Inhibitors to SARS-CoV-2's Enzymes and Potential Disruptors of Its Structural Proteins' Interactions. [PDF]

Adv Biomed Res
Mohammadian A, Jadaliha M, Imanpour A, Pourvali Moghadam H, Jahangir A.   +4 more
europepmc   +1 more source